|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 100.99 USD | +0.01% |
|
-.--% | - |
| Market Cap | 3.32B 2.9B 2.67B 2.49B 4.72B 316B 4.79B 32.03B 12.45B 155B 12.47B 12.2B 536B | P/E 2023 |
-317x | P/E 2024 | 69.3x |
|---|---|---|---|---|---|
| Enterprise Value | 3.48B 3.04B 2.79B 2.6B 4.94B 331B 5.01B 33.54B 13.04B 163B 13.05B 12.77B 561B | EV / Sales 2023 |
1.55x | EV / Sales 2024 | 1.33x |
| Free-Float |
-
| Yield 2023 * |
-
| Yield 2024 | - |
| 25-09-30 | A CEO's Playbook For Navigating Crisis And Building Trust (Video) | AQ |
| 25-07-29 | Amedisys: Q2 Earnings Snapshot | AQ |
| 25-07-29 | Amedisys : Second Quarter 2025 Earnings Release Supplemental Slides | PU |
| 25-07-29 | Amedisys Reports Second Quarter 2025 Financial Results | AQ |
| 25-04-23 | Amedisys: Q1 Earnings Snapshot | AQ |
| 1 day | +0.01% |
| 1 year | 95.99 |  | 101.02 |
| 3 years | 82.15 | | 101.02 |
| 5 years | 69.36 | | 276.21 |
| 10 years | 34.58 | | 325.12 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Ginn
DFI | Director of Finance/CFO | 57 | 2017-10-05 |
Keith Blanchard
CTO | Chief Tech/Sci/R&D Officer | - | - |
Denise Bohnert
CMP | Compliance Officer | 48 | 2016-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25-08-13 | Issuer sale | Director | 16,031 | 0.0489% | ||
| 25-08-13 | Issuer sale | Director | 9,818 | 0.0300% | ||
| 25-08-13 | Issuer sale | Director | 9,335 | 0.0285% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 2.24B 1.96B 1.8B 1.67B 3.18B 213B 3.22B 21.57B 8.39B 105B 8.39B 8.21B 361B | 2.35B 2.05B 1.89B 1.76B 3.34B 224B 3.39B 22.65B 8.8B 110B 8.81B 8.63B 379B |
| Net income | -9.75M -8.52M -7.83M -7.3M -13.84M -928M -14.05M -94.01M -36.55M -456M -36.59M -35.8M -1.57B | 43.23M 37.79M 34.73M 32.37M 61.4M 4.12B 62.33M 417M 162M 2.02B 162M 159M 6.97B |
| Net Debt | 361M 315M 290M 270M 512M 34.35B 520M 3.48B 1.35B 16.88B 1.35B 1.33B 58.18B | 156M 136M 125M 117M 222M 14.86B 225M 1.51B 585M 7.3B 586M 573M 25.17B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- AMED Stock
Select your edition
All financial news and data tailored to specific country editions
